About Replacin
Replacin is a Healthcare company based in Mumbai (India) founded in 2019. It provides contract research and pharmaceutical services including clinical trials and development. It operates on a B2B model. Its Indian entity Replacin Private Limited reported revenue of ₹34.5 Lakh. Replacin offers products and services including Formulation Development, Clinical Trials, Pharmacovigilance, Regulatory Affairs, and Auditing Services. Its focus areas include Biotech, Clinical Research, CRO Services and Regulatory Affairs.
Company details
Replacin Is A Contract Research Organization Based In Mumbai, India, Specializing In Clinical Research Solutions For The Bio-pharmaceutical Sector. It Offers Services Such As Formulation Development, Analytical Method Validation, Clinical Trials, Bioequivalence Studies, And Pharmacovigilance. The Company Collaborates With Pharmaceutical Companies To Expedite Product Development, Ensure Regulatory Compliance, And Deliver High-quality Results Through A Skilled Team, Focusing On Timely And Cost-effective Outcomes For Clients In The Healthcare Industry.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Website replacin-group.com
- Legal Name Replacin Private Limited
- Date of Incorporation 17 Jul, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹34.5 Lakh
FY 2024 · -47% YoY
- Net Loss-₹2.6 Lakh
FY 2024 · -7% margin
- EBITDA-₹1 Lakh
FY 2024 · -3% margin
Associated legal entities of Replacin
Replacin operates through Replacin Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Replacin Private Limited CIN U24290MH2019PTC328159 | Active | 17 Jul 2019 | Mumbai, Maharashtra | ₹0.3 Cr | 4 | View details |
Products & Services of Replacin
Replacin offers a comprehensive portfolio of products and services, including Formulation Development, Clinical Trials, Pharmacovigilance, Regulatory Affairs, and Auditing Services.
Develops pharmaceutical formulations for drug development
Conducts clinical and bioequivalence studies for safety
Monitors drug safety and adverse effects post-marketing
Handles dossier compilation and regulatory submissions
Audits CROs for compliance and quality standards
Board of directors of Replacin Private Limited (Replacin)
Replacin Private Limited is the primary company behind Replacin. The board of Replacin Private Limited currently have 4 directors; the longest-serving is Shrinivas Satish Chavan, appointed in 2025. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shrinivas Satish Chavan DIN 10205034 | Additional Director | 17 Feb 2025 | 1 yr 8 mo | Replacin Private Limited |
| Vijay Shingnapurkar DIN 05133977 | Additional Director | 17 Feb 2025 | 1 yr 8 mo | Replacin Private Limited |
| Jyoti Balasaheb Nimbalkar DIN 10495330 | Additional Director | 17 Feb 2025 | 1 yr 8 mo | Replacin Private Limited |
| Nomaan Azim Shaikh DIN 11251820 | Additional Director | 22 Aug 2025 | 1 yr 2 mo | Replacin Private Limited |
Financials of Replacin
Figures of Replacin Private Limited, the primary company behind Replacin, for FY 2024. Revenue was ₹34.5 Lakh (-47% year on year). Net loss was -₹2.6 Lakh (-7% margin). EBITDA was -₹1 Lakh (-3% margin). Revenue has grown at a compounded annual rate of -10% over three years.
- ₹34.5 LakhRevenue · FY 2024 · -47% YoY
- -₹2.6 LakhNet loss · -7% margin
- -₹1 LakhEBITDA · -3% margin
- ₹1 LakhPaid-up capital
- -10%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Replacin Private Limited are on its company page.
Detailed financial statements for Replacin
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as Replacin (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 50.52 M | 902 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Replacin
Replacin was founded in 2019.
Replacin is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Replacin, Replacin Private Limited, reported revenue of ₹34.5 Lakh for FY 2024, down 47% year on year.
Replacin Is A Contract Research Organization Based In Mumbai, India, Specializing In Clinical Research Solutions For The Bio-pharmaceutical Sector. It Offers Services Such As Formulation Development, Analytical Method Validation, Clinical Trials, Bioequivalence Studies, And Pharmacovigilance. The Company Collaborates With Pharmaceutical Companies To Expedite Product Development, Ensure Regulatory Compliance, And Deliver High-quality Results Through A Skilled Team, Focusing On Timely And Cost-effective Outcomes For Clients In The Healthcare Industry.
Replacin offers Formulation Development, Clinical Trials, Pharmacovigilance, Regulatory Affairs, and Auditing Services.
Replacin operates through Replacin Private Limited.
The legal entities of Replacin currently have 4 directors, including Shrinivas Satish Chavan, Vijay Shingnapurkar, Jyoti Balasaheb Nimbalkar and others.